Impact of duration of bevacizumab (Bev) treatment in the prognosis of adults with recurrent malignant gliomas.
Mohamed Ali Hamza
No relevant relationships to disclose
Charles A. Conrad
Consultant or Advisory Role - Reata Pharmaceuticals
Stock Ownership - Reata Pharmaceuticals
Research Funding - Archer Biosciences
John Frederick De Groot
Consultant or Advisory Role - Genentech
Research Funding - Adnexus; AstraZeneca; Sanofi
Mark R. Gilbert
Consultant or Advisory Role - Abbott Laboratories; Genentech; Merck
Honoraria - Genentech; Merck
Research Funding - Genentech; Merck
Morris D. Groves
Consultant or Advisory Role - Genentech; Merck; Sanofi
Honoraria - Genentech; Merck; Sanofi
W. K. Alfred Yung
Consultant or Advisory Role - Actelion; Merck
Honoraria - Actelion; Merck; Novartis
Research Funding - Daiichi Sankyo; Novartis
Vinay K. Puduvalli
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Bayer; Celgene; Genentech; Merck